In recognition of IBS Awareness Month, Dr. Eyad Alakrad, Consultant Gastroenterologist and Director of GI Motility Services at Sheikh Shakhbout Medical City (SSMC), sheds light on the complexities of Irritable Bowel Syndrome (IBS)—a highly prevalent but often misunderstood disorder. Emphasizing the shift from viewing IBS as a vague “functional disorder”
MEAPEN (The Middle Eastern Alliance for Parenteral and Enteral Nutrition) Congress 2025 concluded on a high note at the Intercontinental Festival City in Dubai, drawing healthcare professionals, clinical nutritionists, pediatric specialists, and thought leaders from across the globe. This year’s event, hosted under the leadership of Dr. Wafaa Ayesh, Chair,
Abbott, the global leader in continuous glucose monitoring (CGM) biowearable technology, today announced that it has entered a first-of-its-kind agreement to integrate data from its world-leading Libre CGM systems directly into Epic’s electronic health record systems in the U.S. The collaboration aims to improve workflow efficiency for providers through Epic’s
Abu Dhabi Global Health Week (ADGHW – second edition) concluded with a renewed commitment to reshaping how the world approaches, invests in, and supports longer, healthier lives. Centered on key themes such as digital health and AI, prevention, personalization, precision medicine, and longevity, the event marked a significant milestone in
DoH (The Department of Health – Abu Dhabi), the regulator of the healthcare sector in the Emirate, convened senior international government officials at the Health Leaders Roundtable to shape a Declaration on AI governance principles for healthcare. Held on the sidelines of Abu Dhabi Global Health Week (ADGHW), it considered
Robotic-assisted surgery is revolutionizing healthcare in the UAE, led by Cleveland Clinic Abu Dhabi’s advanced program. With over 400 procedures in 2024, including groundbreaking kidney transplants and cancer surgeries, robotics is enhancing precision, reducing recovery times, and improving outcomes—positioning the UAE as a global leader in patient-centered, tech-driven medical innovation.
Chronic Obstructive Pulmonary Disease (COPD) is a leading respiratory health challenge globally, with a sharp rise in cases in Saudi Arabia. By 2019, COPD cases exceeded 430,000, a 330% increase since 1990. Contributing factors include smoking, air pollution, and occupational hazards. Notably, Saudi Arabia has introduced new biologic therapies and
Novartis, a global leader in innovative medicines, and the Emirates Dermatology Society (EDS) have announced the renewal of their strategic partnership aimed at transforming dermatological care in the United Arab Emirates. Now in its third year, the collaboration remains focused on addressing high-impact immunological skin conditions, including Psoriasis, Hidradenitis Suppurativa
Cleveland Clinic Abu Dhabi, part of the M42 group, successfully completes pioneering technology for hearing loss treatment in the UAE, with the successful completion of the first active middle ear implant. This groundbreaking procedure, performed on a 63-year-old female patient suffering from complex mixed hearing loss and chronic ear infections
Get notified about new articles
